RIVA, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 7.295
EU - Europa 4.819
AS - Asia 3.039
SA - Sud America 318
Continente sconosciuto - Info sul continente non disponibili 80
AF - Africa 38
OC - Oceania 4
Totale 15.593
Nazione #
US - Stati Uniti d'America 7.218
IT - Italia 2.267
SG - Singapore 1.001
UA - Ucraina 802
CN - Cina 683
VN - Vietnam 441
TR - Turchia 385
SE - Svezia 348
DE - Germania 310
HK - Hong Kong 306
BR - Brasile 278
FR - Francia 254
FI - Finlandia 249
IE - Irlanda 204
GB - Regno Unito 156
RU - Federazione Russa 112
IN - India 63
BD - Bangladesh 48
CA - Canada 40
JP - Giappone 31
NL - Olanda 26
MX - Messico 22
BE - Belgio 20
PL - Polonia 18
AR - Argentina 13
EU - Europa 13
ZA - Sudafrica 13
IQ - Iraq 12
SA - Arabia Saudita 9
PK - Pakistan 8
ES - Italia 7
PH - Filippine 7
AT - Austria 6
CH - Svizzera 6
CO - Colombia 6
LT - Lituania 6
UZ - Uzbekistan 6
ID - Indonesia 5
JO - Giordania 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
EC - Ecuador 4
EG - Egitto 4
PE - Perù 4
TN - Tunisia 4
AU - Australia 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
MA - Marocco 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
CR - Costa Rica 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
PA - Panama 2
SN - Senegal 2
UY - Uruguay 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
CL - Cile 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GR - Grecia 1
GY - Guiana 1
IS - Islanda 1
JM - Giamaica 1
KR - Corea 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MV - Maldive 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RW - Ruanda 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 15.524
Città #
Milan 1.569
San Jose 624
Jacksonville 608
Chandler 586
Fairfield 578
Singapore 517
Ashburn 503
Woodbridge 388
Dearborn 317
Hong Kong 302
Ann Arbor 280
Houston 254
Wilmington 251
Princeton 215
Beijing 203
Seattle 203
Dublin 202
Izmir 190
Nyköping 183
Council Bluffs 173
Cambridge 171
Dallas 145
Boardman 127
Rome 118
The Dalles 116
Dong Ket 110
New York 98
Lauterbourg 93
Chicago 88
San Mateo 88
Los Angeles 86
Ho Chi Minh City 75
Como 71
Munich 53
San Diego 50
Hanoi 47
Orem 42
Ogden 41
Helsinki 40
Santa Clara 33
Buffalo 32
Guangzhou 29
Hefei 29
Tokyo 29
São Paulo 26
Chennai 24
London 23
Kunming 20
Nanjing 18
Turku 18
Brussels 17
Manchester 16
Warsaw 16
Denver 15
Jinan 15
Verona 15
Atlanta 14
Poplar 14
Norwalk 13
Amsterdam 12
Brooklyn 12
Da Nang 12
Düsseldorf 12
Nanchang 12
Phoenix 12
San Francisco 12
Washington 12
Toronto 11
Boston 10
Frankfurt am Main 10
Hangzhou 10
Montreal 10
Rio de Janeiro 10
Catania 9
Mexico City 9
New Delhi 9
Ankara 8
Haiphong 8
Johannesburg 8
Pune 8
Casorezzo 7
Changsha 7
Fuzhou 7
Shenyang 7
Stockholm 7
Tianjin 7
Auburn Hills 6
Baghdad 6
Biên Hòa 6
Campinas 6
Nuremberg 6
Redwood City 6
Shanghai 6
Vienna 6
Amman 5
Belo Horizonte 5
Chengdu 5
Florence 5
Hải Dương 5
Kocaeli 5
Totale 10.557
Nome #
Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis 322
LUTEOMA GRAVIDICO CON ASCITE MASSIVA: DESCRIZIONE DI UN CASO 283
Microsatellite analysis of sporadic and hereditary gynaecological cancer in routine diagnostics 261
Durable recurrence-free survival after pneumonectomy for late lung metastasis from rectal cancer: Case report with genetic and epigenetic analyses 251
Carcinosarcoma of the uterine cervix: Case report and discussion. 239
Inherited cancer syndromes in 220 Italian ovarian cancer patients 239
A cell-autonomous oncosuppressive role of human RNASET2 affecting ECM-mediated oncogenic signaling 233
Somatic Testing on Gynecological Cancers Improve the Identification of Lynch Syndrome 231
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase. 229
Biochemical and immunohistochemical characterization of human RNASET2 expression 219
Natural history of cervical intraepithelial neoplasia during pregnancy. 218
Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers 214
Two Cases of Carcinosarcomas of the Ovary Involved in Hereditary Cancer Syndromes 214
Primary Extranodal Marginal Cell Lymphoma, MALT Type, of the Endometrium Arising in a Patient With Rheumatoid Arthritis: Report of a Case 212
Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis 209
Endometrial cancer cells can express fibrinogen: Immunohistochemistry and RT-PCR analysis 207
Renal cell carcinoma metastatic to a pituitary FSH/LH adenoma: Case report and review of the literature 200
Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesis 197
Primary peritoneal cancer in Lynch syndrome: a clinical-pathologic report of a case and analysis of the literature. 185
Identifying factors contributing to reduced breast tumor size: A longitudinal study 182
Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences 176
Early Involvement of 6q in Surface Epithelial Ovarian Tumors 176
Tumor suppression by means of microenvironment-mediated stress response: the role of the human RNASET2 gene 173
"Proximal type" epithelioid sarcoma of the vulva: differential diagnosis with other extrarenal rhabdoid tumors 169
Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study 169
Breast carcinomas with neuroendocrine features are neoplasms of low grade malignancy 162
Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involement in benign surface epithelial ovarian tumours 161
Targeted gene sequencing of Lynch syndrome–related and sporadic endometrial carcinomas 161
Human RNASET2 mediates tumor suppression by means of in vivo recruitment of stromal cells 160
Fetoplacental cytomegalovirus infection. A case report 158
CD44 expression in ER and PR negative ductal breast carcinomas 158
Chromosome 6 abnormalities in borderline ovarian tumours suggest a genetic continuum in the progression model of ovarian neoplasms. 156
Disorders of the Endocrine System 155
Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms 154
6q27 contains candidate genes involved in surface epithelial ovarian tumors. 4th congress of the European Society for Gynecologic and Obstetric Investigation, Madonna di Campiglio, 14-20 marzo, 1999 154
Adenohypophyseal differentiation in ovarian mature cystic teratomas and in ovarian carcinoids 152
Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. 152
Ovarian metastases from colorectal carcinoma. Clinicopathologic profile, immunophenotype, and karyotype analysis 151
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene. 148
Calretinin expression in different molecular subtypes of ER and PR negative breast carcinomas 148
RNASET2 expression in ovarian epithelial tumors and clinico-pathological correlations. 146
Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001 145
The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas. 145
Intraoperative radioimmunoguided of colo-rectal cancer using monoclonal antibody B72.3 labelled with 125I 143
IDENTIFICAZIONE E TIPIZZAZIONE DEI GENOTIPI HPV AD ALTO RISCHIO NELLE LESIONI PRENEOPLASTICHE DELLA CERVICE UTERINA: CORRELAZIONI CLINICOPATOLOGICHE 142
Diabetic fibrous mastopathy: sonographic-pathologic correlation 142
Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma. 141
Instabilità dei microsatelliti e perdita dell’espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici 140
IMMUNOPHENOTYPIC EVALUATION OF ESTROGEN AND PROGESTERONE RECEPTORS NEGATIVE BREAST CARCINOMAS 139
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro 139
Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts 139
Microsatellite instability in endometrial cancer. Relation to histological subtypes 138
Androgen receptors in breast 137
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas 136
Prognostic significance of karyotype analysis in ovarian carcinomas 136
Clinico-pathological correlations of karyotype analysis in ovarian carcinomas 135
Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells.Neoplasia 133
Carcinoma lobulare in situ e invasivo: studio di clonalità con mtDNA 132
Ovarian retiform Sertoli-Leydig cell tumor : clinicopathological study of a case, 22th Int Meeting of the Adriatic Society of Pathology 130
RNASET2 is a non-cell autonomous human tumor suppressor 130
Clinicopathological features of oral carcinoma: analysis of 240 cases 129
Espressione del recettore degli androgeni nel carcinoma mammario 128
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment 128
METILAZIONE DE NOVO DI p16, hMLH1 E MGMT NEI CARCINOMI SINCRONI ENDOMETRIALI E OVARICI 127
Immunohistochemical expression and methilation status of MGMT in diffuse large B-cells lymphomas 125
Histopathology, hormone products, and clinico-pathologic profile of endocrine tumors of the small intestine. A study of 44 cases. 122
Rnaset2, the first human ribonuclease of the rh/t2/s family, displays a role in tumor suppression 121
LONG-TERM FOLLOW-UP OF IN SITU CARCINOMA OF THE BREAST 120
Chromosome 6 abnormalities in borderline tumors suggest a genetic continuum in the progression model of ovarian neoplasms 120
“Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas” 119
Pituitary adenomas, a thirty-four-years experience in a –single institution. 117
Prognostic significance of p53 CA 19-9 and M3SI expression in ovarian carcinomas. 117
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas 115
Instabilità dei microsatelliti e perdita dell'espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici 113
Microsatellite instability and lack of hMLH1 expression in syncronous endometrial and ovarian carcinomas 113
Chromosome 6 abnormalities are frequently expressed in Borderline Ovarian Epithelial Tumors suggesting a progression model of ovarian carcinogenesis 113
Correlation between microsatellite instability, clinico-pathological and immunohistochemical features in endometrial carcinomas 112
Capitolo 9.7: Intestino tenue 112
PLACENTAL MALARIA AS A CAUSE OF INTRPAUTERINE FETAL DEATH IN ASYMPTOMATIC PATIENT. A CASE REPORT 110
ESTROGEN RECEPTOR NEGATIVE INVASIVE BREAST CARCINOMAS FREQUENTLY EXPRESS MYOEPITHELIAL MARKERS 110
Non-chromaffin paraganglioma of the cervix uteri. Immunohistochemical and ultrastructural study 110
Ki67, p53 and pttg-1 expression in invasive pituitary adenomas. 109
Er negative, p53 positive, breast cancers frequently express basal and myoepithelial cell markers 106
The applications of FISH in tumor pathology 105
Clinico - Pathological profile of Estrogen and Progesteron receptors negatibe breast cancinomas with basal or luminal markers expression 104
Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas 104
IL CARCINOMA MICROINVASIVO DELLA CERVICE 103
p53 positive, breast cancers frequently express basal and myoepithelial cell markers 103
Frequency and chacterization of anterior pituitary component in ovarian mature cystic teratomas. 103
Ovarian metastases: clinico-pathological profile, immunophenotype and Karyotype analysis 102
Expression of gastrointestinal markers in pancreatic carcinomas 99
Capitolo 9.6: Stomaco 99
Prognostic significance of karyotype analysis in ovarian carcinomas 98
Molecular genetics of syncronous endometrial and ovarian carcinomas 97
Correlazioni cisto-isto-colposcopiche in 150 casi consecutivi di patologia cervicale. 97
CLINICO-PATHOLOGICAL PROFILE OF ESTROGEN AND PROGESTERONE NEGATIVE BREAST CARCINOMAS WITH BASAL OR LUMINAL MARKERS EXPRESSION 96
Ano 96
Gestione per processi in anatomia patologica. Strumenti di analisi del rischio di errore. Azioni correttive e di miglioramento 95
Clinicopathological features of neuroendocrine carcinomas (NECs) of the breast 94
Capitolo 9.8: Colon-retto 94
Totale 14.891
Categoria #
all - tutte 60.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022948 0 126 96 76 46 37 37 69 53 161 83 164
2022/20231.460 127 99 105 195 91 299 3 201 219 35 59 27
2023/20242.348 394 388 400 413 470 149 9 17 57 16 17 18
2024/20251.448 9 21 264 41 49 59 50 81 214 113 137 410
2025/20263.566 263 221 121 569 361 222 717 201 392 249 141 109
2026/2027267 114 153 0 0 0 0 0 0 0 0 0 0
Totale 15.593